Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp210 | Diabetes: Pharmacotherapy | ECE2019

Empagliflozin inhibits apoptosis of pancreatic beta-cells through amelioration of ER-stress.

Nasiri-Ansari Narjes , Dimitriadis Georgios K. , Angelousi Anna , Tsara Anna , Lembesis Panayiotis , Kiaris Hippokrates , Papavassiliou Athanasios G. , Randeva Harpal S. , Kassi Eva

Introduction: Type 2 diabetes mellitus (T2DM) is characterized by progressive impairment/ loss of pancreatic beta cell function Activation of endoplasmic reticulum (ER) stress by glucose variation has been suggested as an essential step towards beta cell dysfunction. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely used in the treatment of T2DM considering their beneficial cardiometabolic sequalae. In the present study, we aimed to investigate the effect of Empag...

ea0063p140 | Diabetes, Obesity and Metabolism 1 | ECE2019

Predictors of incident hypertension in healthy, non-diabetic postmenopausal women with normal renal function

Stamatelopoulos Kimon , Apostolakis Michael , Augoulea Areti , Paschou Stavroula A , Armeni Eleni , Panoulis Konstantinos , Bakas Panagiotis , Georgiopoulos Georgios , Kaparos George , Rizos Dimitrios , Lambrinoudaki Irene

Introduction: The aim of this study was to investigate the incidence of hypertension and to identify potential risk factors in healthy, non-diabetic recently postmenopausal Greek women with normal renal function.Patients and methods: In this retrospective cohort study, we evaluated 141 recently postmenopausal women at baseline and annually thereafter (follow-up time: 1 to 8 years). Blood samples were obtained and ultrasound evaluations were performed at ...

ea0063p217 | Diabetes, Obesity and Metabolism 1 | ECE2019

Metabolic health is strongly predicted by free Testosterone and SHBG levels in non-obese postmenopausal women

Armeni Eleni , Paschou Stavroula A , Augoulea Areti , Rizos Dimitrios , Kaparos George , Soureti Anastasia , Karagouni Iliana , Georgiopoulos Georgios , Stamatelopoulos Kimon , Syggelos Nikolaos , Lambrinoudaki Irene

Introduction: Ovarian senescence and fluctuating levels of sex hormones is associated with metabolic derangement and central obesity. The aim of this study was to explore the association between serum levels of sex hormones and metabolic health in non-obese postmenopausal women.Patients and methods: This cross-sectional study included a total of 457 non-obese postmenopausal (BMI <30 kg/m2) women, retrieved from the Menopause Clinic of Aret...

ea0063p218 | Diabetes, Obesity and Metabolism 1 | ECE2019

The presence of polymorphic variant A1298C of the MTHFR (methylenetetrahydrofolate reductase) gene is associated with lower body mass index in girls with anorexia nervosa

Paschou Stavroula A , Deligeoroglou Evangelia , Economou Emmanuel , Armeni Eleni , Papadimitriou Georgios , Stergioti Evgenia , Karountzos Vassilios , Tsitsika Artemis K , Augoulea Areti , Panoulis Konstantinos , Lambrinoudaki Irene

Introduction: Single nucleotide polymorphic variants of the methylenetetrahydrofolate reductase (MTHFR) gene have been related with a tendency to gain weight according to recent studies. The aetiology of atypical anorexia nervosa remains under investigation and might be associated with the genetic background. The aim of this study was to evaluate the association between the presence of A1298C or C677T polymorphisms of the MTHFR gene and weight status in a sample of adolescent ...

ea0063p350 | Thyroid 1 | ECE2019

Outcomes of surgery and radioiodine treatment for neck recurrence in papillary thyroid cancer

Kalaitzidou Styliani , Tampouratzi Dimitra , Papadakis Georgios , Karavasili Chrysi , Triantafillou Eleni , Kanouta Fotini , Sapera Aggeliki , Kotis Michalis , Aravantinou Aggeliki , Roumpidaki Zoi , Dracopoulou Anna , Kaltzidou Victoria , Veniou Irini , Tertipi Athanasia

Background: Persistent/recurrent disease in the neck is frequent in patients with papillary thyroid cancer. The main goal of this study was to evaluate the efficacy of the reoperation and radioiodine (RAI) treatment for persistent/recurrent disease after the initial treatment. Patients and Methods: A total of 30 patients (13 M/17 F) with papillary thyroid cancer were enrolled in this study. Seven cases (23.3%) had an aggressive subtype of papillary carcinoma. All had been subm...

ea0063p383 | Thyroid 1 | ECE2019

Clinical presentation of patients with Autoimmune Polygranular Syndrome III (APS III)

Sapera Ageliki , Papadakis Georgios , Tampouratzi Dimitra , Kalaitzidou Styliani , Karavasili Chrysi , Kotis Michail , Aravantinou Ageliki , Roumpidaki Zoi , Dracopoulou Anna , Kaltzidou Victoria , Veniou Irini , Tertipi Athanasia

Background: The autoimmune polyglandular syndromes are clusters of endocrine abnormalities that occur in discreet patterns in subjects with immune dysregulation and that permit treatment and anticipation of associated systemic or other hormonal deficiencies. Three major entities are recognized, APS I, APS II and APS III. They are considered rare syndromes, but they are possibly not always thoroughly investigated. APS III, in contrast to APS I and II, does not involve the adren...

ea0063p464 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

EGFR and IGF1R affect Sunitinib activity: novel targets for Broncho-Pulmonary Neuroendocrine Neoplasm treatment

Bresciani Giulia , Ditsiou Angeliki , Cilibrasi Chiara , Vella Viviana , Rea Federico , Schiavon Marco , Cavallesco Narciso Giorgio , Giamas Georgios , Zatelli Maria Chiara , Gagliano Teresa

Background: Available medical treatments for Broncho-Pulmonary Neuroendocrine Neoplasm (BP-NENs) derived from clinical trials are not specific for the management of this malignancy. Sunitinib, a multi-receptor tyrosine-kinases (RTKs) inhibitor, mainly described as VEGFR inhibitor, has shown its efficacy in Pancreatic NENs but there are not available data about its action in BP-NENs. Our aim was to understand the effects of RTKs inhibition promoted by Sunitinib in order to eval...

ea0063p678 | Pituitary and Neuroendocrinology 2 | ECE2019

Case report of pituitary adenoma with subclinical Cushing’s disease

Tampouratzi Dimitra , Kalaitzidou Styliani , Papadakis Georgios , Karavasili Chrysi , Kotis Michalis , Sapera Ageliki , Aravantinou Ageliki , Roumpidaki Zoi , Dracopoulou Anna , Kaltzidou Victoria , Tertipi Athanasia

Background: Subclinical Cushing disease is defined by mild hypercortisolism that results from a corticotroph pituitary adenoma, without any typical sign of the disease. The patients often have coexisting metabolic diseases such as diabetes mellitus, and hypertension. Conversely, silent corticotroph adenomas demonstrate normal cortisol secretion, but positive immunochemistry for ACTH, most usually without ACTH hypersecretion, although they and can progress to clinical Cushing d...

ea0063p833 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

The role of somatostatin analogs in the control of carcinoid syndrome: systematic review and meta-analysis

Alexandraki Krystallenia , Angelousi Anna , Chatzellis Eleftherios , Chrisoulidou Alexandra , Kalogeris Nikolaos , Kanakis Georgios , Savvidis Christos , Vassiliadi Dimitra , Toulis Konstantinos , Tsagarakis Stylianos , Kaltsas Gregory

Introduction: Somatostatin analogues (SSAs) are the mainstay of treatment for carcinoid syndrome (CS)-related symptoms. Controversy still exists regarding the extent of the efficacy of this intervention. The purpose of the systematic review and meta-analysis was to evaluate the percentage of patients achieving partial (PR) or complete response (CR) with the use of SSAs (lanreotide, octreotide, pasireotide) in patients with CS. Due to lack of uniformity and established criteria...

ea0049gp15 | Adrenal 2 | ECE2017

Integrated genomic and phenomic analysis reveals key molecular pathways of aldosterone producing adenoma

Fernandes-Rosa Fabio , Boulkroun Sheerazed , Dzib Felipe Golib , Daniil Georgios , Amar Laurence , Rance Bastien , Samson-Couterie Benoit , Jeunemaitre Xavier , Meatchi Tchao , Benecke Arndt , Strom Tim , Zennaro Maria-Christina

Primary aldosteronism is the most common form of secondary hypertension. Somatic mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D have been described in 50% of aldosterone producing adenomas (APA). To identify genetic alterations in new genes, we performed whole exome sequencing in 23 patients with APA negative for recurrent mutations in known driver genes. A low number of somatic variations were identified per patient, ranging from 1 to 22. N...